바이오인

 

 

 

IP, INNOVATION AND ECONOMIC PERFORMANCE ........................................................... 6
  Valuation and exploitation of patents .................................................................................... 6
  Competition policy issues ............................................................................................... 7
  Open innovation ................................................................................................................... 8
  Econometric studies on the determinants of R&D and patenting ........................................ 8
IP AND THE PUBLIC SECTOR ................................................................................................ 9
  IP in public research and academic patenting ............................................................... 9
  Research use of patented inventions .............................................................................. 9
  OECD Principles and Guidelines for Access to Research Data from Public Funding ......... 10
  Digital access and commercial re-use of public sector information (PSI) .......................... 10
  Scientific publishing and digital delivery .............................................................................11
THE GLOBAL DIMENSION .................................................................................................... 12
  Combating counterfeiting .................................................................................................... 12
  Counterfeiting and piracy of pharmaceuticals ............................................................. 12
  IP in China .......................................................................................................................... 13
  International trade-related aspects of IP ............................................................................ 13
  IP management in international technology collaboration ................................................. 14
IP IN THE INFORMATION SOCIETY .................................................................................... 14
  Digital content creation, access, distribution and copyrights .................................... 15
  Digital rights management .................................................................................................. 15
  Internet domain name system .................................................................................. 16
BIOTECHNOLOGY ................................................................................................................. 16
  OECD Guidelines for the Licensing of Genetic Inventions .................................................. 16
  Collaborative mechanisms for the management of IP ........................................................ 17
  Bioeconomy ............................................................................................................. 17
PATENT STATISTICS AND METHODOLOGICAL WORK .................................................... 18